PHARMACODYNAMICS AND CLINICAL USE OF GUANETHIDINE, BRETYLIUM AND METHYLDOPA

被引：36

作者：

KIRKENDALL, WM

WILSON, WR

机构：

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1962年 / 9卷 / 01期

关键词：

D O I：

10.1016/0002-9149(62)90104-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：107 / &

相关论文

共 28 条

[1] ABBOUD FM, PERSONAL COMMUNICATI
[2] ABBOUD FM, 1961, CLIN RES, V9, P136
[3] BOURA ALA, 1959, LANCET, V2, P17
[4] CLINICAL PHARMACOLOGY OF BRETYLIUM TOSYLATE - PRELIMINARY OBSERVATIONS
CONWAY, J
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) : 956 - 963
[5] DOLLERY CT, 1960, LANCET, V1, P296
[6] DOYLE AE, 1960, BRIT MJ, V5196, P422
[7] EMMELIN N, 1960, LANCET, V2, P263
[8] FINNERTY FA, CITED INDIRECTLY
[9] SELECTIVE INHIBITION OF THE SYMPATHETIC NERVOUS SYSTEM IN MAN WITH BRETYLIUM TOSYLATE, A NEW ANTIHYPERTENSIVE AGENT
FREIS, ED
SUGIURA, T
LIPTAK, D
[J]. CIRCULATION, 1960, 22 (02) : 191 - 197
[10] CLINICAL PHARMACOLOGY OF NEWER ANTIHYPERTENSIVE AGENTS, MONOAMINE OXIDASE AND DECARBOXYLASE INHIBITORS, BRETYLIUM TOSYLATE, AND GUANETHIDINE
GILLESPIE, L
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1960, 88 (04) : 1011 - 1020